Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
1991 | New monoclonal antibody against human cervical carcinoma with diagnostic and therapeutic potential | Roffler, S. R.; Yu, M. H.; Chen, M. R.; Chen, S. C.; Hsu, C. T.; Yeh, M. Y. | Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 24, 19-29 | | | |
1997 | Poly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs | Cheng, T. L.; Chen, B. M.; Chan, L. Y.; Wu, P. Y.; Chern, J. W.; Roffler, S. R. | Cancer Immunol Immunother 44, 305-315 | | | |
2001 | Potentiation of antitumor immunity by antibody-directed enzyme prodrug therapy | Chen, B. M.; Cheng, T. L.; Tzou, S. C.; Roffler, S. R. | Int J Cancer 94, 850-858 | | | |
1994 | Potentiation of radioimmunotherapy by inhibition of topoisomerase I | Roffler, S. R.; Chan, J.; Yeh, M. Y. | Cancer Res 54, 1276-1285 | | | |
2000 | Presence of cloning vector sequences in the untranslated region of some genes in Genbank | Liao, K. W.; Chang, Y. W.; Roffler, S. R. | J Biomed Sci 7, 529-530 | | | |
2000 | Proactive antitumor compounds | Roffler, S. R.; Chern, J. W.; Leu, Y. L. | US Patent #6,043,367 | | | |
2003 | Proactive antitumor compounds | Roffler, S. R.; Chern, J. W.; Leu, Y. L. | European Patent EP0990661 | | | |
2005 | Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes | Sher, Y. P.; Shih, J. Y.; Yang, P. C.; Roffler, S. R.; Chu, Y. W.; Wu, C. W.; Yu, C. L.; Peck, K. | Clin Cancer Res 11, 173-179 | | | |
2005 | Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes | Sher, Y. P.; Shih, J. Y.; Yang, P. C.; Roffler, S. R.; Chu, Y. W.; Wu, C. W.; Yu, C. L.; Peck, K. | Clin Cancer Res 11, 173-179 | | | |
2000 | Protein 4.1R binding to eIF3-p44 suggests an interaction between the cytoskeletal network and the translation apparatus | Hou, C. L.; Tang, C.; Roffler, S. R.; Tang, T. K. | Blood 96, 747-753 | | | |
2001 | Sensitive measurement of polyethylene glycol-modified proteins | Tsai, N. M.; Cheng, T. L.; Roffler, S. R. | Biotechniques 30, 396-402 | | | |
1992 | Specific activation of glucuronide prodrugs by antibody-targeted enzyme conjugates for cancer therapy | Wang, S. M.; Chern, J. W.; Yeh, M. Y.; Ng, J. C.; Tung, E.; Roffler, S. R. | Cancer Res 52, 4484-4491 | | | |
2003 | Stability of the new prodrug 9-aminocamptothecin glucuronide (9ACG) in the presence of human serum albumin | Prijovich, Z. M.; Leu, Y. L.; Roffler, S. R. | Biochem Pharmacol 66, 1181-1187 | | | |
2003 | Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity | Liao, K. W.; Chen, B. M.; Liu, T. B.; Tzou, S. C.; Lin, Y. M.; Lin, K. F.; Su, C. I.; Roffler, S. R. | Cancer Gene Ther 10, 779-790 | | | |
2004 | Surfection: a new platform for transfected cell arrays | Chang, F. H.; Lee, C. H.; Chen, M. T.; Kuo, C. C.; Chiang, Y. L.; Hang, C. Y.; Roffler, S. R. | Nucleic Acids Res 32, e33 | | | |
2004 | The immunization site of cytokine-secreting tumor cell vaccines influences the trafficking of tumor-specific T lymphocytes and antitumor efficacy against regional tumors | Chang, C. J.; Tai, K. F.; Roffler, S. R.; Hwang, L. H. | J Immunol 173, 6025-6032 | | | |
1991 | Therapy of human cervical carcinoma with monoclonal antibody-Pseudomonas exotoxin conjugates | Roffler, S. R.; Yu, M. H.; Chen, B. M.; Tung, E.; Yeh, M. Y. | Cancer Res 51, 4001-4007 | | | |
2003 | Tumor-associated antigen L6 and the invasion of human lung cancer cells | Kao, Y. R.; Shih, J. Y.; Wen, W. C.; Ko, Y. P.; Chen, B. M.; Chan, Y. L.; Chu, Y. W.; Yang, P. C.; Wu, C. W.; Roffler, S. R. | Clin Cancer Res 9, 2807-2816 | | | |
2008 | Tumor-targeting prodrug-activating bacteria for cancer therapy | Chuang, K. H.; Hung, W. C.; Shiea, J.; Su, Y. C.; Kao, C. H.; Chen, B. M.; Roffler, S. R.; Cheng, Tian-Lu | Cancer Gene Therapy 15, 393-401 | | | |